News & Perspective

Feb 12, 2019

Feb 12, 2019

News Scan for Feb 12, 2019

More Saudi MERS cases
Yellow fever in Brazil
Lassa fever in Guinea and Nigeria
Zika in Mexico
Gain-of-function H5N1 studies to resume

Jan 18, 2019

Jan 18, 2019

ASP Scan (Weekly) for Jan 18, 2019

New CARB-X funding
VRE in Swiss hospitals
Antibiotic overprescribing in tots
Fast track for new C diff drug
Stewardship in pediatric surgery
MRSA decline in Germany
Antibiotic resistance on pig farms
Resistance genes in Bolivian river
Stewardship in English hospitals
Whiff of C diff in pets
Fecal microbiota transplant trial

Jan 10, 2018

Jan 10, 2018

News Scan for Jan 10, 2018

Ebola antibody findings
USDA egg product rule
1918 pandemic flu severity

Nov 03, 2017

Nov 03, 2017

ASP Scan (Weekly) for Nov 03, 2017

Livestock-related MRSA
Antimicrobial stewardship recognition
IV antibiotics for UTIs
MRSA vaccine candidate
MCR-1 in pigs
MRSA and patient-sharing
Pneumonia overprescribing
New CARB-X funding
Hospital ASPs
Wales superbug deaths decline
Antibiotics in nursing homes

Aug 14, 2013

Aug 14, 2013
H5N1 color electron micro

Study: Technique adds 'kill switch' to modified flu viruses

A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.

May 28, 2008

May 28, 2008

Some avian flu H7 viruses growing more human-like

(CIDRAP News) – Scientists have found evidence that North American avian influenza viruses of the H7 subtype are becoming more like human flu viruses in their ability to attach to host cells, which suggests they may be improving their capacity to infect humans.

Jun 27, 2005

Jun 27, 2005

Momentum builds for cell-culture flu vaccines

(CIDRAP News) – You've got to gather a lot of eggs to supply the world with influenza vaccine, but that might change before long.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»